402 related articles for article (PubMed ID: 19749141)
1. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
Sokol H; Beaugerie L
Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
Subramaniam K; D'Rozario J; Pavli P
J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
[TBL] [Abstract][Full Text] [Related]
3. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
[TBL] [Abstract][Full Text] [Related]
4. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
Beaugerie L; Sokol H; Seksik P
Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
[TBL] [Abstract][Full Text] [Related]
5. Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.
Subramaniam K; Cherian M; Jain S; Latimer M; Corbett M; D'Rozario J; Pavli P
Intern Med J; 2013 Dec; 43(12):1339-42. PubMed ID: 24330365
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated lymphoproliferative disorders.
Rezk SA; Weiss LM
Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
[TBL] [Abstract][Full Text] [Related]
7. [Lymphoproliferative disorders in an inflammatory bowel disease unit].
Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E
Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478
[TBL] [Abstract][Full Text] [Related]
8. [Inflammatory bowel disease and lymphoproliferative disorders].
Ye BD
Korean J Gastroenterol; 2011 Oct; 58(4):171-7. PubMed ID: 22042416
[TBL] [Abstract][Full Text] [Related]
9. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
Kwon JH; Farrell RJ
Crit Rev Oncol Hematol; 2005 Oct; 56(1):169-78. PubMed ID: 15979323
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.
Lelièvre JD; Sacre K; Adle-Biassette H; Molinier-Frenkel V; Gaulard P; Papo T
J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):24-7. PubMed ID: 15692507
[TBL] [Abstract][Full Text] [Related]
11. [Inflammatory bowel diseases and lymphoma].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
Beaugerie L
Dig Dis; 2012; 30(4):415-9. PubMed ID: 22796808
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus, lymphoma risk and the potential role of HIV infection in IBD patients undergoing immunosuppression.
Weinstock DM
Dig Dis; 2010; 28(3):519-24. PubMed ID: 20926881
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L
J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lymphoproliferative disorder complicating infectious mononucleosis in an immunosuppressed patient.
Owen CE; Callen JP; Bahrami S
Pediatr Dermatol; 2011; 28(2):149-55. PubMed ID: 20497356
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous Epstein-Barr virus-related lymphoproliferative disorders in 4 immunosuppressed children.
Wallet-Faber N; Bodemer C; Blanche S; Delabesse E; Eschard C; Brousse N; Fraitag S
J Am Acad Dermatol; 2008 Jan; 58(1):74-80. PubMed ID: 17884243
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
[TBL] [Abstract][Full Text] [Related]
18. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.
Lapsia S; Koganti S; Spadaro S; Rajapakse R; Chawla A; Bhaduri-McIntosh S
J Med Virol; 2016 Feb; 88(2):312-8. PubMed ID: 26307954
[TBL] [Abstract][Full Text] [Related]
20. Posttransplantation lymphoproliferative disorders.
Andreone P; Gramenzi A; Lorenzini S; Biselli M; Cursaro C; Pileri S; Bernardi M
Arch Intern Med; 2003 Sep; 163(17):1997-2004. PubMed ID: 14504111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
